Stock Market Today: Dow Falls On New Trump Tariffs; Novo Plunges On Drug Trial Results (Live Coverage)
Stock Market Today: The Dow Jones index dropped Monday on higher Trump tariffs. Novo stock plunged on weight-loss drug trial results.
BTC
ETH
USDT
XRP
USDC
SOL
TRX
FIGR_HELOC
DOGE
WBT
USDS
HYPE
LEO
ADA
BTC
ETH
USDT
XRP
USDC
SOL
TRX
FIGR_HELOC
DOGE
WBT
USDS
HYPE
LEO
ADA
BTC
ETH
USDT
XRP
USDC
SOL
TRX
FIGR_HELOC
DOGE
WBT
USDS
HYPE
LEO
ADA
BTC
ETH
USDT
XRP
USDC
SOL
TRX
FIGR_HELOC
DOGE
WBT
USDS
HYPE
LEO
ADA
Bitcoin bulls avoided a correction as US markets opened, but analysis warned that Strategy was responsible for much of the latest BTC price strength.
Most popular articles this week
Latest news from global stock markets, tech giants, and financial sectors
Browse ArticlesBitcoin, Ethereum, altcoins, DeFi, NFTs, and blockchain technology
Browse ArticlesGold, silver, oil, natural gas, and other precious commodities
Browse Articles
Stock Market Today: The Dow Jones index dropped Monday on higher Trump tariffs. Novo stock plunged on weight-loss drug trial results.
The Austrian Financial Market Authority has frozen new business at KuCoin EU months after granting the exchange a MiCA license, citing gaps in key AML and...
Gilead to acquire cancer therapy developer Arcellx for up to $7.8 billion
Psyence Biomedical stock gains on equity investment deal
The February jobs report, and not the Supreme Court ruling overturning a large part of President Donald Trump's tariffs on imported goods, will be key to w...
Tariffs need to become law or the federal budget will take a hit. Lawmakers have less than 150 days to decide.
Airline stocks are taking a hit as a major Northeast snowstorm is leading to thousands of flight cancellations.
Honeywell International on Monday received a 26% discount on its deal to acquire a business tied to the struggling chemicals industry.
Polymarket Shows 72% Odds Bitcoin Falls Below $55K The post Polymarket Shows 75% Odds of Bitcoin Dropping Below $55K âEUR" What Traders Need to Know appear...
Decent growth, benign inflation, a dovish Fed and a weaker dollar all favor equities but international and emerging stocks look set to build on the outperf...
Novo Nordisk shares were under pressure on Monday as the struggling Danish pharmaceutical said a head-to-head study found a drug in development didn't cut...
Novo Nordisk's obesity drug CagriSema falls short against Eli Lilly's in trial